SEC Filing Details

Document Details

Filing Date
Apr 16, 2019
Document Date
Apr 16, 2019
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb